$1.29
+0.16 (+14.16%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,849.6% upside
Low Target
$26.78
Average Target
$38.05
High Target
$46.02
Current Price
$1.29
Current
$1.29
$1.29
Target
$38.05
$38.05
$26.78
$38.05 avg
$46.02
Scenario Analysis
Bear Case
$26.78
1,976.0%
Low target
Base Case
$38.05
+2,849.6%
Avg target
Bull Case
$46.02
+3,467.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.97
-56.6% from high
52-Week Low
$0.69
+87.3% from low
Target vs 52W High
$38.05
+1,181.1% vs high
Next Earnings Report
Sep 24, 2026 · After Market Close
1d
tomorrow
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |